FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer

FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance

(2016) Y Yu-Rice et al.   ONCOGENE

Cryopreservation of Endothelial Cells in Various Cryoprotective Agents and Media – Vitrification versus Slow Freezing Methods

(2016) Achim von Bomhard et al.   PLoS One

Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells

(2016) Yumei Diao et al.   Oncotarget

TGEV infection up-regulates FcRn expression via activation of NF-κB signaling

(2016) Jinyue Guo et al.   Scientific Reports

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

(2016) Paige Maas et al.   JAMA Oncology

Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging

(2015) S. V. Bachawal et al.   CANCER RESEARCH

Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ER -Positive Breast Cancer

(2015) E. A. Peterson et al.   CANCER RESEARCH

ERR  Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

(2015) S. Manna et al.   CLINICAL CANCER RESEARCH

Epigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor–Resistant Cutaneous Melanomas

(2015) Jinhua Wang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer

(2015) X Xue et al.   ONCOGENE

FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer

(2014) C Gong et al.   ONCOGENE

Nuclear Respiratory Factor 2β (NRF-2β) Recruits NRF-2α to the Nucleus by Binding to Importin-α:β via an Unusual Monopartite-Type Nuclear Localization Signal

(2013) Rippei Hayashi et al.   JOURNAL OF MOLECULAR BIOLOGY

Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function

(2013) A S Beltran et al.   ONCOGENE

Diagnostic performance and application of two commercial cell viability assays in foot-and-mouth disease research

(2011) Tom Willems et al.   JOURNAL OF VIROLOGICAL METHODS

FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

(2010) P. S. Ray et al.   CANCER RESEARCH

Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling

(2010) Ying Qu et al.   JOURNAL OF CLINICAL INVESTIGATION

Sustained c-Jun-NH2-Kinase Activity Promotes Epithelial-Mesenchymal Transition, Invasion, and Survival of Breast Cancer Cells by Regulating Extracellular Signal-Regulated Kinase Activation

(2010) J. Wang et al.   MOLECULAR CANCER RESEARCH

Gene expression of forkhead transcription factors in the normal and diseased human prostate

(2009) Leonie van der Heul-Nieuwenhuijsen et al.   BJU INTERNATIONAL

RETRACTED ARTICLE: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

(2009) Aamir Ahmad et al.   BREAST CANCER RESEARCH AND TREATMENT

Transcriptional Regulation of Estrogen Receptor-  by p53 in Human Breast Cancer Cells

(2009) S. H. Shirley et al.   CANCER RESEARCH

KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα

(2009) K Akaogi et al.   ONCOGENE

MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer

(2008) Jian-Jun Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

FoxA1 as a lineage-specific oncogene in luminal type breast cancer

(2007) Noritaka Yamaguchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS